Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-14

Clinical Trial Update: LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update for LE Gel in treating ocular inflammation and pain after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LE Gel

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract, Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-04-14